Cargando…

B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients

To elucidate cross-sectional patterns and longitudinal changes of oral and stool microbiota in multiple sclerosis (MS) patients and the effect of B-cell depletion. We conducted an observational, longitudinal clinical cohort study analysing four timepoints over 12 months in 36 MS patients, of whom 22...

Descripción completa

Detalles Bibliográficos
Autores principales:	Troci, Alba, Zimmermann, Olga, Esser, Daniela, Krampitz, Paula, May, Sandra, Franke, Andre, Berg, Daniela, Leypoldt, Frank, Stürner, Klarissa Hanja, Bang, Corinna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904534/ https://www.ncbi.nlm.nih.gov/pubmed/35260584 http://dx.doi.org/10.1038/s41598-022-07336-8

Ejemplares similares

Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report
por: Jacksch, Clemens, et al.
Publicado: (2023)

Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis
por: Stürner, Klarissa Hanja, et al.
Publicado: (2020)

A case of CLIPPERS syndrome responsive to tocilizumab
por: Rempe, Torge, et al.
Publicado: (2019)

Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases – a retrospective cross-sectional study
por: Brauchle, Felix, et al.
Publicado: (2023)

Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
por: Stürner, Klarissa Hanja, et al.
Publicado: (2019)

Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
por: Stellmann, Jan-Patrick, et al.
Publicado: (2015)

Comprehensive Implementation of Shared Decision Making in a Neuromedical Center Using the SHARE TO CARE Program
por: Stolz-Klingenberg, Constanze, et al.
Publicado: (2023)

Turning When Using Smartphone in Persons With and Those Without Neurologic Conditions: Observational Study
por: Bianchini, Edoardo, et al.
Publicado: (2023)

The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens
por: Frost, Fabian, et al.
Publicado: (2020)

Pesticides and the Microbiome-Gut-Brain Axis: Convergent Pathways in the Pathogenesis of Parkinson’s Disease
por: Kulcsarova, Kristina, et al.
Publicado: (2023)

Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximab
por: Rosenkranz, Sina C., et al.
Publicado: (2021)

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
por: Stoessel, Daniel, et al.
Publicado: (2018)

Postural Sway in Parkinson's Disease and Multiple Sclerosis Patients During Tasks With Different Complexity
por: Warmerdam, Elke, et al.
Publicado: (2022)

Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
por: Pisani, Anthea, et al.
Publicado: (2022)

Dysbiosis of the microbiome in gastric carcinogenesis
por: Castaño-Rodríguez, Natalia, et al.
Publicado: (2017)

Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Oral Microbiome in Health and Disease: Maintaining a Healthy, Balanced Ecosystem and Reversing Dysbiosis
por: Maier, Tom
Publicado: (2023)

Evolutionary modeling suggests that addictions may be driven by competition-induced microbiome dysbiosis
por: Lewin-Epstein, Ohad, et al.
Publicado: (2023)

Dysbiosis of skin microbiome and gut microbiome in melanoma progression
por: Mekadim, Chahrazed, et al.
Publicado: (2022)

Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosis
por: Pell, Nuria, et al.
Publicado: (2021)

Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

The Importance of a Healthy Microbiome in Pregnancy and Infancy and Microbiota Treatment to Reverse Dysbiosis for Improved Health
por: DuPont, Herbert L., et al.
Publicado: (2023)

Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin
por: Johnson, Michael E., et al.
Publicado: (2019)

Extreme Dysbiosis of the Microbiome in Critical Illness
por: McDonald, Daniel, et al.
Publicado: (2016)

Mucosal microbiome dysbiosis in gastric carcinogenesis
por: Coker, Olabisi Oluwabukola, et al.
Publicado: (2018)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

Microbiome dysbiosis and alcoholic liver disease(☆)
por: Li, Fengyuan, et al.
Publicado: (2019)

The Association of Microbiome Dysbiosis With Colorectal Cancer
por: Artemev, Artem, et al.
Publicado: (2022)

Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
por: Miyake, Sachiko, et al.
Publicado: (2015)

Interconnections between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance between Systemic Health and Disease
por: Khor, Brandon, et al.
Publicado: (2021)

Reverse Microbiomics: A New Reverse Dysbiosis Analysis Strategy and Its Usage in Prediction of Autoantigens and Virulent Factors in Dysbiotic Gut Microbiomes From Rheumatoid Arthritis Patients
por: Wang, Haihe, et al.
Publicado: (2021)

Heart Failure Severity Closely Correlates with Intestinal Dysbiosis and Subsequent Metabolomic Alterations
por: Spehlmann, Martina E., et al.
Publicado: (2022)

Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging
por: Thaler, Christian, et al.
Publicado: (2021)

Current Perspectives on Gut Microbiome Dysbiosis and Depression
por: Capuco, Alexander, et al.
Publicado: (2020)

Microbiome and Its Dysbiosis in Inborn Errors of Immunity
por: Sharma, Madhubala, et al.
Publicado: (2023)

Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period
por: Faizy, Tobias Djamsched, et al.
Publicado: (2017)

Normal gut microbiome in NMDA receptor encephalitis
por: Herken, Julia, et al.
Publicado: (2019)

Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
por: Bayas, Antonios, et al.
Publicado: (2023)

Microbiome and Metabolome Insights into the Role of the Gastrointestinal–Brain Axis in Parkinson’s and Alzheimer’s Disease: Unveiling Potential Therapeutic Targets
por: Zacharias, Helena U., et al.
Publicado: (2022)

Meta-analysis of microbiome association networks reveal patterns of dysbiosis in diseased microbiomes
por: Lam, Tony J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qbj7m73v9hunpadnkf7umduu52